Last reviewed · How we verify

NCT06569615

Efficacy of Extracorporeal Shock Wave Therapy, LASER Therapy and Cryotherapy in Patients Having Sacroiliitis

Recruiting now NA Last updated 25 February 2026
What this trial tests

NA trial testing shock wave therapy in Sacroilitis in 60 participants. Currently enrolling.

Timeline
27 August 2024
Primary endpoint
5 March 2026
5 March 2026

Quick facts

Lead sponsorNajran University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date27 August 2024
Primary completion5 March 2026
Estimated completion5 March 2026
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Najran University

Who can join

Adults 20 to 50, male only, with Sacroilitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aimed to determine the effect of extracorporeal shock wave therapy, LASER therapy and cryotherapy on PPT, Pain and functional disability in patients having Sacroiliitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of shock wave therapy

Trials testing the same drug.

Other recruiting trials for Sacroilitis

Currently open trials in the same condition.

Other Najran University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06569615.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing